Mosquito-borne diseases threaten lives and livelihoods, physicians and the public differ on views of these public health threats.

thumbnail_infographic_mosquito-borne-diseases

Mosquito-Borne Diseases: Critical Disconnects Between Physicians and Public

Andrew S. Plump, MD, PhD, President of Research & Development at Takeda Pharmaceutical Company Limited, discusses  changes needed in the way we approach science to achieve cures.

What Will It Take to Deliver Cures to Society?

Top U.S. academic life science researchers report near universal interest in translating their innovations to bring more cures to market, yet the majority also want external resources and allies for the journey, reports the 2024 Cure Translational Research Survey.

Fueling Engines of Innovation Image Asset

Fueling Engines of Innovation Image

Fueling Engines of Innovation

Blue

With more than $2.5 billion raised since 2019, BioLabs@NYULangone is giving healthcare entrepreneurs the tools, capital access, and collaborative ecosystem needed to accelerate innovation in life sciences.

How BioLabs Builds a Launchpad for Life Science Startups image

How BioLabs@NYULangone Builds a Launchpad for Life Science Startups

The BioVenture eLab, part of Weill Cornell Medicine Enterprise Innovation, equips innovators with business expertise, funding pathways, and investor connections to accelerate the translation of ideas to the marketplace.

Turning Research into Healthcare Startups: Weill Cornell Medicine’s BioVenture eLab

Richard Magid, PhD, Vice President of Technology Transfer at Colorado State University explains how university faculty and students can navigate IP, licensing, and partnerships to commercialize healthcare discoveries.

From Lab to Market: How Tech Transfer Turns Research into Real-World Impact image

From Lab to Market: How Tech Transfer Turns Research into Real-World Impact

As fewer PhDs remain in academic research, institutions are embedding career development early in training, equipping scholars with skills, networks, and confidence to thrive across the healthcare and life sciences ecosystem.

Helping PhDs Thrive in Industry

More PhDs are trading academia for entrepreneurship. Founders from Aggregate Biosciences, Celmatix Therapeutics, Daré Bioscience, Gameto, GenKardia and Metallomix share how mentorship, business acumen, and the right support systems can turn discoveries into thriving startups.

From Lab Bench to Startup: How Scientists Can Make the Leap 

Accelerators and incubators both offer mentorship, resources, and investor access, but their structures, timelines, and risks vary. Here’s what healthcare entrepreneurs need to know to choose what’s best for their startup.

Accelerator vs. Incubator: Which is Right for Your Healthcare Startup?

Core facilities equip healthcare innovators with shared access to advanced technologies, expert support and collaborative insights to accelerate discovery while reducing costs.

How Core Facilities Accelerate Healthcare Innovation

Experts from Novastone Capital Advisors and CORE IR share how capitalization tables reveal startups' decision-making power, dilution risks, IP ownership, and exit potential.

Decoding Capitalization Tables: The Healthcare Founder’s Map of Ownership, Dilution, and Control

Chat GPT-5 offers faster reasoning, multimedia support, and scalable efficiency that create opportunities for healthcare companies to boost productivity, improve health literacy, and expand access to underserved populations.

What Chat GPT-5 Means for Healthcare Startups and Providers

At a time when federal funding is shrinking, healthcare startups are finding critical support from mission-driven venture philanthropies like the ADDF and LLS willing to back early-stage, high-risk science.

Is Venture Philanthropy Right for Your Startup? Here’s How to Tell

CEOs of Veravas, Persephone Bioscience, and Citius Pharmaceuticals reveal what it takes to helm your own startup, the mistakes that can derail you, and how to know when it’s time to step aside.

Should You Be Your Healthcare Startup’s CEO? Founders Weigh In

Crowdfunding can offer mission-driven healthcare startups early traction and autonomy, but founders must navigate investor perceptions, regulatory complexity, and platform tradeoffs.

Should you Crowdfund your Healthcare Startup?

Should You Crowdfund Your Healthcare Startup?

The Gates Foundation’s $2.5 billion pledge is historic, but founders say it’s only a starting point. Here’s how they want the money to be spent, and why more bold action is still needed.

Women’s Health Founders React to Gates Foundation $2.5 Billion Pledge Image

Women’s Health Founders React to Gates Foundation $2.5 Billion Pledge

A sweeping new CMS initiative, backed by the White House, will create a secure, interoperable app store for Medicare, offering startups unprecedented access to health data and a massive user base.

Startups Get Early Shot at Building Tools for U.S. Health Data Network Image 16-9

Medicare's New App Store Opens a $1 Trillion Market to Health Startups

Reggie Swift, PhD, Rubix LS Founder and CEO, is revolutionizing clinical research by designing inclusive, data-driven clinical trials that reflect the diversity of real-world patients, helping healthcare innovators, CROs, and agencies transform health equity and outcomes.

How Rubix LS is Reengineering Clinical Trials HERO image

How Rubix LS is Reengineering Clinical Trials for Real-World Impact image

How Rubix LS is Reengineering Clinical Trials for Real-World Impact

Pitch competitions can boost credibility, sharpen your strategy, and connect you with investors—but they also demand time and focus. Here's how to decide if they’re worth it for your startup.

Should You Enter a Pitch Competition? What Healthcare Startups Need to Know HERO image

Should You Enter a Pitch Competition? What Healthcare Startups Need to Know

Monica Cepak is redefining what it means to lead in healthcare. She’s transforming Wisp into a fearless, first-to-market platform for women’s sexual and reproductive health, normalizing taboo topics, and launching new verticals.  

Thumbnail-Monica Cepak-CEO-Wisp-1920x1080

Monica Cepak’s Playbook for Scaling Wisp as a Brand Women Actually Trust

As Series B capital gets harder to secure, companies raise more in earlier rounds to reach value milestones.

‘Barbell Effect’ Reshapes Funding for Healthcare Entrepreneurs Image HERO

‘Barbell Effect’ Reshapes Funding for Healthcare Entrepreneurs

Funding experts reveal how healthcare entrepreneurs’ messaging can build trust, communicate value, and position your startup for long-term success.

What Not to Say to Investors: 5 Messaging Mistakes That Can Derail Your Pitch

Nell Smircina of Novastone Capital Advisors and Vivian Cervantes of CORE IR explain how founders should approach valuation and why getting it wrong can cost you more than funding.

What Every Healthcare Startup Needs to Know About Valuation

Newly released FDA complete response letters offer healthcare entrepreneurs insight into why drug applications fail and how to avoid the same mistakes.

What Startups Can Learn from FDA ‘No’ Letters

Open-source biological datasets Boltz-2 and Tahoe-100M are helping resource-strapped healthcare entrepreneurs and academic scientists accelerate drug discovery using AI but without the high data costs.

How Public Data Fuels the Next Wave of Drug Innovation

Leaders from NYCEDC, Ally Bridge Group and Hunter College share how mentorship drives innovation, sharpens leadership skills, and expands professional networks.

Mentoring Pays Off: How Guiding Others Can Boost Your Own Career

Faced with shrinking budgets, academic and industry life science researchers are making strategic partnerships their top priority.

Why Scientists and Startups are Doubling Down on Partnerships in 2025

OFFOR Health and LOUD Capital founder Navin Goyal, MD, breaks down five proven B2B models, from subscriptions to data licensing, and reveals the biggest mistake healthcare entrepreneurs make when selling to providers and payers.

5 B2B Revenue Models Every Healthcare Startup Should Consider

Nell Smircina of Novastone Capital Advisors and Vivian Cervantes of CORE IR explain how choosing the right mix of advisors can support your company’s mission and milestones.

Your Healthcare Startup Needs an Advisory Board—Here’s How to Build One That Matters

16-year-old entrepreneur Khartik Uppalapati, co-founder of the RareGen Youth Network, is combining AI innovation and advocacy to reshape how rare diseases are diagnosed and addressed globally.

How a Teen Turned His Rare Diagnoses into a Rare Movement

CMS’s new Cell and Gene Therapy Access Model allows states to offer sickle cell gene therapies through federally negotiated contracts, reshaping CGT market for startups and rare disease therapeutics.



New Federal Program Expands Access to Gene Therapies for Sickle Cell and More

Scaling a startup is more than just growth. Founders from G9 Ventures, Evvy, Inflect Health, and Kindbody offer six tips to preserve trust, brand, and purpose as your company gets larger.

Scaling Smart: How to Grow Women’s Health Startups 

Ali Chappell, PhD, RD, Co-Founder and CEO of Lilli Health, shares how she transformed her experience with PCOS into a data-driven nutrition and wellness company offering services and app to have “a dietitian in your pocket.”


How a PCOS Diagnosis Fueled One Founder’s Mission to Disrupt Women’s Health

Robyn Riseberg, MD, shares how she founded Boston Community Pediatrics as the first nonprofit private pediatric practice to bring integrated healthcare to children in Boston.

Reimagining Pediatric Care: How One Nonprofit is Setting a New Standard for Health Equity

Strong mentorships can accelerate your entrepreneurial journey. Experts from NYCEDC, Ally Bridge Group, and Hunter College share how to communicate, build trust and get the most out of a mentor relationship.

6 Tips to Maximize Your Mentor Relationship

The Supreme Court’s decision upholding preventive care coverage under the Affordable Care Act signals a stable, growing market for healthcare startups and entrepreneurs.

Supreme Court Upholds Preventive Care Mandate — What It Means for Healthcare Innovation

Founders behind Teal Health, Proov, Sunny, and Bloomlife reveal lessons from their FDA experiences, from unexpected reclassifications to trial redesigns to funding gaps.

How MedTech Startups Navigate the FDA: Lessons from Women’s Health Innovators

The EU’s top health official said reforms will make Europe more attractive for drug developers as FDA changes create industry uncertainty.

Europe Makes Bold Bid to Attract Biotech Amid FDA Uncertainty

The International Center for Professional Development connects underrepresented scholars and African entrepreneurs with healthcare industry mentors, training and opportunities.

How Mentoring Programs Fuel Pipeline of Healthcare Entrepreneurs 

The shortage of anti-obesity medications is sending patients to gray markets while healthcare innovators look for longer-term solutions beyond of GLP-1s.

How Entrepreneurs are Looking Beyond GLP-1s for Obesity Innovations

When VCs say no, founders are tapping alternative sources, from academic accelerators and angel investors to strategic industry partnerships and mission-aligned family offices, to bring solutions to market.


Beyond VC: 6 Ways to Fund Your Healthcare Startup

Founders behind Elektra Health, Frame Fertility, Gabbi, and OOVA share how trial, error and trust shaped their GTM journeys.

4 Women’s Health Entrepreneurs Reveal Go-to-Market Strategies image

4 Women’s Health Entrepreneurs Reveal Go-to-Market Strategies

Mentors are trusted allies whose valuable experience-based wisdom can open doors for healthcare entrepreneurs navigating from startup to longterm success.

5 Smart Ways to Find a Mentor Who Moves Your Healthcare Career Forward

NYU Langone’s Marc Sedam shares how, amid sweeping federal cuts to scientific research, some U.S. universities are quietly rewriting the funding playbook for moving discoveries from lab to market.

Marc Sedam NYU Langone Thumbnail Image

Universities Step Up as Translational Funders Amid NIH Uncertainty

CEO Mary Beth Cicero says women’s health startups face hurdles even with novel ideas and real-world demand.

Mary Beth Cicero 3 Daughters Thumbnail Image

Breakthrough IUD Faces Familiar Funding Barrier in Women’s Health

Healthcare industry executives at BIO paint a picture of optimism for the sector's future amid policy changes and technological disruptions.

6 executives Betty Woo, PhD  and Daniella Cramp image

6 Executives on How Resilience, Not Retreat, Defines the Healthcare Year Ahead

Ernst & Young’s latest report shows biotech investors remain cautious in 2025, but innovation and partnerships offer path for a rebound.

Biotech Seeks Turnaround as Investors Focus on Fundamentals

Entrepreneurs Jenny Carillo, Roya Pakzad, and Mike Satow advise on how to healthcare companies can prepare for acquisitions, from bankers and buyers to IP and partnerships. 

How to Exit Smart:  7 Mistakes Healthcare Founders Should Avoid 

Despite reductions and restructuring, the FDA is strong and on track to meet its goals, FDA Commissioner Martin Makary, MD, said at BIO.

FDA Commissioner Pushes Aggressive Overhaul Amid Biotech Uncertainty

New data from Cure reveals how healthcare entrepreneurs are betting on AI to reshape drug development, advance rare disease treatments, and reduce clinical and financial barriers to innovation.

AI Emerges as Healthcare’s Bright Spot Amid Industry Upheaval image

AI Emerges as Healthcare’s Bright Spot Amid Industry Upheaval

The FDA is setting new priorities designed to bring innovative healthcare products to market faster, though concerns about political interference at federal science agencies complicate the picture.

FDA Shares New Priorities and ‘Proactive’ Approach to Working with Developers

Equal Research Day highlights the persistent disparity of women in medical research and elevates leaders working to change that. Cure spotlights seven women shaping a more equitable future in healthcare innovation.

7 Women Advocates Who Drive Gender Equity in Health Research image 1

7 Women Advocates Who Drive Gender Equity in Health Research

Five healthcare entrepreneurs share pivotal mentorship advice that helped them navigate career shifts and overcome scientific setbacks.

What My Mentor Taught Me: Healthcare Entrepreneurs Share Lessons Learned

The U.S. faces a tipping point in science and innovation, with top experts urging bold reforms to reverse declines in research funding, talent, and global influence.

Reclaiming U.S. Scientific Leadership: A Wake-Up Call for Innovators

How can improving care options lead to unlocking profitability? Women’s health entrepreneurs from Daré Biosciences, Organon, and Willow offered insights at the 2025 SiS New York Conference.

Thumbnail SiS video Seema Kumar Sabrina Johnson Dare

6 Ways to Make Women’s Health Profitable

New reports from Jefferies and J.P. Morgan offer a split-screen view of biotech’s rough start and its potential recovery in the second half of 2025.

Best or Worst of Times for U.S. Healthcare? Analysts Split on Outlook

Harvard and MIT respond to federal crackdown on international students and research funding.

Trump Administration Action Against Harvard Sparks Backlash, Scientific Talent War

Lux Capital's initiative offers money, mentorship and migration pathways to keep scientific discoveries alive amidst rising international competition for America's innovators.

Lux Capital Launches $100M ‘Helpline’ for U.S. Scientists

As biopharmas report first quarter earnings, executives are being asked to respond to the Trump administration’s many changes to the business environment, regulatory scene and domestic manufacturing.

Drugmakers Brace for Trump-Era Shifts on Tariffs, Manufacturing and Regulation

During the 2025 XSeed Award ceremony, a panel of biotech investors, policy experts, and founders offered hard-earned advice to early-stage entrepreneurs navigating a volatile funding landscape.

Experts Urge Healthcare Startups to Stay Bold, Focused, and Patient-Centered

Two NYC-based startups, GenKardia and Sidereal Therapeutics, have each won a $250,000 XSeed Award to support moving promising preclinical research of novel therapies for kidney and heart disease forward toward commercialization.

$250K XSeed Awards Granted to Minority- and Women-Led Startups Advancing New Drugs 

After a career championing entrepreneurs and science policy at BIO, E. Cartier Esham, PhD, launched her own firm to help healthcare innovators navigate Washington, DC, and shape the future of medicine

From Bench Scientist to Policy Powerhouse: E. Cartier Esham’s Entrepreneurial Pivot

Small businesses can secure non-dilutive funding through the NIH SBIR program to develop healthcare technologies and services that overcome barriers to care for populations experiencing health disparities.

NIH Offers $10 Million in Grants for Startups Tackling Health Disparities

Adiutrix Therapeutics is developing a novel targeted therapy for the lung-stiffening disease known as idiopathic pulmonary fibrosis, offering the potential to be safer and more potent than current treatments.

How a Startup Targets a Deadly Lung Disease

Sidereal Therapeutics is developing a potential first-in-class biologic to prevent acute kidney injury from progressing to chronic disease by targeting iron overload at its source.

Novel Biologic Aims to Stop Kidney Damage Before it Turns Chronic

Vasocure is advancing targeting therapies to prevent arteriovenous graft (AVG) stenosis for patients on kidney dialysis that may also unlock new treatments for atherosclerosis.

How One Company Targets Dialysis Complications with Novel Therapy

From Hibernating Bears to Human Heart Failure: A New Therapeutic Path image

From Hibernating Bears to Humans: A New Therapeutic Path for Heart Failure 

XSeed Award finalist Aggregate Biosciences is developing precision diagnostics and therapeutics aiming to transform treatment for Alzheimer’s, type 2 diabetes, and other amyloid-related diseases.

How This Company is Fighting Alzheimer's With a New Approach to Amyloid

Technological innovation and clinical research are opening new doors for entrepreneurs to tackle spine surgery’s diagnostic gaps, improve outcomes, and reduce healthcare costs.

How Entrepreneurs Could Disrupt Spine Surgery

Sunbird Bio's platform aims to address a $20 billion global neurology diagnostics market to test for Alzheimer’s, Parkinson’s, ALS and more. 

How Sunbird Bio is Changing Brain Disease Diagnoses  

Scientists are scrambling to manage surging costs as President Trump's sweeping tariffs on imported laboratory equipment begin to bite.

Trump Tariffs Strain Science Research Budgets for Lab Equipment

CEO Marissa Fayer draws on her engineering background to lead DeepLook Medical and advises women’s health startups to think big, stay strategic, and seek broader investor support.

Women’s Health CEO Shares Advice on Raising Funds: Be Direct

A new federal report warns that America’s biotech leadership is slipping behind China, calling for a $15 billion investment plan to boost innovation and protect national interests.

U.S. Falling Behind in Biotech, Government Warns

U.S. Urged to Invest $15 Billion in Biotech to Counter China

Tia Health is reshaping women’s healthcare experiences with primary care in-person clinics that offer collaborative, holistic patient-centric approach.

thumbnail_tia_ceo_felicity_yost_image

How Tia Stays Competitive in a Crowded Healthcare Landscape

While biopharma struggles attracting investors, AI, non-opioid pain medications, cell and gene therapies and metabolic diseases are still finding funding. 

How AI Moonshots Nailed Biotech Funding in Bleak Quarter

Healthcare innovators can network and learn at upcoming 2025 conferences that bring together life science, biotech and entrepreneurship thought leaders.

5 Top Conferences for Healthcare Innovators Image

What 2025 Events are Must-Attends for Healthcare Innovators?

Sunbird Bio’s CEO shares how focus, timing, and smart scaling can turn biotech volatility into long-term value.

4 Steps to Building a Biotech Company That Lasts image

4 Steps to Building a Biotech Company That Lasts

Former FDA Commissioner Margaret Hamburg, MD, warns that restricting global partnerships in biomedical research, public health and healthcare policy could weaken the U.S. industry.

Why Margaret Hamburg says Healthcare Needs to Stay Global  

The Power of X Summit gathers entrepreneurs, finance, policy and scientific leaders to address investment gaps and accelerate innovation in women’s health.

Power of X Summit Makes Investment Case for Women’s Health

Cure’s Power of X Women’s Health Summit convened over 200 leaders to catalyze action around the health challenges women face, generating key takeaways and targeted strategies for investors, policymakers and entrepreneurs.

Solutions for the Health of Women

While the Trump administration slashes government grants to early-stage research that has played a critical role in drug development, researchers provide advice on how to influence government representatives to push back.

Mayhem, Destruction and Biomedical Tumult from Trump Cuts

LunaJoy, a mental health provider for women, won the Impact Challenge at Cure's Power of X Summit, securing $110,000 in funding and services to help address the critical gap in women’s healthcare innovation.

LunaJoy Wins Impact Challenge at Power of X Summit article image

LunaJoy Wins Impact Challenge at Power of X Summit

LunaJoy Wins Impact Challenge at Cure's Power of X Summit

Yael Weiss, MD, PhD, founder and CEO of Mahzi Therapeutics, shares her path to biotech leadership, offering insights on navigating the male-dominated industry and championing patient-centered innovation.

Mahzi Therapeutics CEO's Advice for Biotech Female Founders

Former FDA Commissioner Margaret Hamburg, MD, discusses the impact of federal layoffs, the erosion of public trust in science, and the risks of undermining U.S. leadership in biomedical research. 


Federal Layoffs Deeply Concern Former FDA Commissioner image

Federal Layoffs Deeply Concern Former FDA Commissioner

Montai Therapeutics, led by former Google executive Margo Georgiadis, is using AI to transform drug discovery by identifying and optimizing natural compounds, expanding access to small-molecule treatments for chronic diseases.

How an Unconventional CEO is Reimagining Drug Discovery

Lime Therapeutics Pioneers Therapies Targeting Lipid Biology image

Lime Therapeutics Pioneers Therapies Targeting Lipid Biology

Biotech wasn’t sure what to expect under a second Trump term. Industry leaders and analysts predict policy shifts could benefit innovation and drug pricing reform.

AI-Powered Companies Dominate 2025 Digital Health Funding

Cure’s Landmark Report Reveals 87% of Healthcare Leaders Remain Optimistic About Future, Despite Challenges

Your Home in NYC

November 11 -13 , 2025

Cure Presents: The X Factor Healthcare Innovation Summit

Accelerating Advances in Health

Entrepreneurship

Insights

Recommended Topics

Join our community